Dopamine d2 Receptor anticorps (AA 307-336)

N° du produit ABIN7873732

Cet anticorps anti-Dopamine d2 Receptor Polyclonal Lapin (ABIN7873732) détecte spécifiquement Dopamine d2 Receptor dans WB. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Dopamine d2 Receptor anticorps (AA 307-336) (ABIN7873732)

Antigène: Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Dopamine d2 Receptor est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-Dopamine d2 Receptor anticorps

Épitope: AA 307-336

Fonction: DRD2 Antibody / Dopamine D2 Receptor

Purification: Antigen affinity purified

Immunogène: A portion of amino acids 307-336 from the human protein were used as the immunogen for the DRD2 antibody.

Isotype: Ig Fraction

Information d'application

Indications d'application: The stated application concentrations are suggested starting points. Titration of the DRD2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the DRD2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur Dopamine d2 Receptor

Antigène: Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

Autre désignation: DRD2

Sujet: This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia, other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing.

UniProt: P14416

Pathways: Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity